The sale is small and routine for an executive exercising options; no material signal for the stock. Monitor for any larger insider sales or changes in executive holdings in future Form 4 filings.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 12 $43.65entry
- T+1 · 4d ago +1.95%α +2.31% · $44.50
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Richard Daniell, Executive VP European Commercial at Teva, filed a Form 144 notice of intent to sell 20,003 ordinary shares with an estimated market value of approximately $856,155 based on the filing's reference price. The sale is tied to a stock option exercise and compensation, and the shares were to be sold on or about November 11, 2026. The proposed sale represents a small fraction of the company's $50.2B market cap and is a routine insider transaction.
Key Facts
- Insider: Richard Daniell, Executive VP European Commercial
- Proposed sale: 20,003 ordinary shares
- Estimated market value: approximately $856,155 (based on filing reference price of ~$42.80 per share)
- Sale date: on or about November 11, 2026
- Nature of transaction: stock option exercise and sale for compensation
- Teva market cap: $50.2B; sale represents ~0.0017% of market cap
Financial Impact
Sale of 20,003 shares worth ~$856K, a de minimis amount relative to Teva's $50.2B market cap
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur
- No unusual insider selling pattern detected; this appears routine
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001973379-26-000369 |
| Document: 0001973379-26-000369-index.html | 0001973379-26-000369 |
| Document: 0001973379-26-000369.txt | 0001973379-26-000369 |
Track record
61 reports on TEVA
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Viewing Entry $43.65 Now $42.57 −2.47% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers